大型抑郁症患者治疗期间自杀念头的变化:一个为期6个月的自然主义后续研究
Aoi Sato1, Norio Sugawara1, Yasushi Kawamata1
1Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, Japan.
Neuropsychopharmacology reports
|March 5, 2024
概括
大型抑郁症 (MDD) 患者的自杀念头 (SI) 通常持续存在. 怀疑和年轻的年龄预测了长时间的SI,有助于临床预测MDD过程.
科学领域:
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
- 神经科学是一个神经科学.
背景情况:
- 自杀念头 (SI) 是主要抑郁障碍 (MDD) 中的一个关键问题.
- 在MDD患者中演变SI的预测因素仍未得到充分研究.
- 自然主义观察提供了对现实世界SI轨迹的洞察.
研究的目的:
- 在MDD患者中,在六个月内划分SI的变化.
- 确定持续性SI的人口和临床预测因素.
- 为管理MDD与自杀念头的临床实践提供信息.
主要方法:
- 对257名MDD患者的截面和纵向分析.
- 使用抑郁症症状快速清单 (QIDS-J) 进行SI评估.
- 在基线评估人格特征 (TIPI-J) 和精神病症状 (PRIME屏幕修订).
主要成果:
- 36.2%的初始MDD患者报告SI.
- 在完成研究的人中,14.3%的人经历了长时间的SI.
- 长时间的SI与怀疑/迫害思想和年轻的年龄有关.
结论:
- 超过三分之一的初始SI的MDD患者经历了长时间的SI.
- 识别可疑性和年龄有助于预测SI持久性.
- 这些发现支持对高危MDD患者进行加强的临床监测.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
229
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
229
Depression: Overview
243
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
243
Depressive Disorders: MDD and Dysthymia
127
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
127
Antidepressant Drugs: Overview
485
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
485
Mania and Antimanic Drugs: Overview
179
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
179
Electroconvulsive Therapy
39
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
39


